newsletter masthead
June 28, 2019
Don't Forget: Register for the Case CCC's Annual Scientific Retreat
Next month, our entire center will come together - one of the few times a year we have the opportunity to do so - to collaborate and enjoy each other's company at the center's Annual Scientific Retreat July 25 and 26.

The retreat agenda is now available with TED-style talks from prominent Cleveland research leaders, a reception, keynote, scientific presentations and breakout sessions for programs that you won't want to miss!

All students, postdocs, and fellows conducting cancer research are invited to  submit abstracts by next Friday, July 5 for the retreat. Cancer Center leadership will review abstracts based on the relationship to cancer, novelty, significance of findings and clarity.  Register for retreat today>
Join Team Case CCC for VeloSano 6: Cheer, Volunteer, Donate or Ride!
July 19-21, 2019 | Cleveland, OH

We are officially less than one month away from VeloSano Bike to Cure weekend! To-date, Team Case CCC has 70 members  who are committed to cancer research, prevention, treatment and cures and have  raised $29,448  and counting. We've grown by 5 members and raised $3,200 in the past week!

While we are still welcoming riders to our team, you can also get involved by volunteering for our cheer station or donating to any rider or the team as a whole to show your support!
6th Annual Data Science in Life Science and Engineering Symposium
Aug 5-6, 2019 | Tinkham Veale University Center

Mark your calendars for Aug 5-6, 2019 as the Case Western Reserve University (CWRU) School of Medicine
CWRU SOM logo - png
along with the School of Engineering will be hosting faculty members and students from Tohoku University (Sendai, Japan) for a 2-day data and life science symposium at the Tinkham Veale University Center. 

The symposium brings together researchers from CWRU and Tohoku University to discuss and share ideas on data science in engineering and life science. Symposium sessions will include topics on systems biology and biomedical informatics as well as immunology and metabolomics. A poster session will feature data science research from students, postdocs and faculty of CWRU and Tohoku University. For inquiries, please contact Maita Diaz at or Pearline Cartwright at
NCCN Policy Summit: Defining, Measuring, and Applying Quality in an Evolving Health Policy Landscape and the Implications for Cancer Care
Sep 12, 2019 | Washington, DC

The National Comprehensive Cancer Network is hosting a policy summit on September 12 in Washington, DC. NCCN logo
The summit will present diverse perspectives related to defining, measuring, and paying for quality as cancer care is inundated with innovative, personalized, and high-cost interventions. Experts in the field will discuss the role of outcomes-based oncology quality measures in policy decision-making, including how the patient experience is considered and applied in clinical decision-making. The summit will also evaluate how clinical utility and personalized medicine outcomes shape the health care system. These discussions will culminate with how the various measures, policies, and regulations ultimately impact patient care.  Register today>
Registration Now Open: Artificial Intelligence in Oncology Symposium
Oct 24, 2019 | Tinkham Veale University Center

On October 24, the Case Comprehensive Cancer Center will host the inaugural Artificial Intelligence in Oncology Symposium: Advancements in Policy at Case Western Reserve University.

The symposium will bring together experts in AI and machine learning  as well as clinical, industry and federal agency experts in pathology, radiology, oncology and immuno-oncology to speak on research developments, regulatory policy, reimbursement and ethics surrounding AI.

Symposium Highlights:
  • Focused panel discussions
  • Networking opportunities
  • Exhibitions available throughout the day
Be sure to register by August 30, 2019 to secure our discounted early bird registration. A discounts for students and trainees who wish to attend is available. We look forward to seeing you in October!  Save your seat>
Innovators in AYA Cancer: Driving Science and Policy toward a Brighter Future for Teens and Young Adults with Cancer
Nov 14-15, 2019 | Tinkham Veale University Center
Save the date for the Case Comprehensive Cancer Center's AYA Oncology Symposium taking place November 14-15, 2019 at Tinkham Veale University Center at Case Western Reserve University! Sign up to receive updates>
Opportunities for Pilot Projects to Utilize the Integrated Microbiome Core
Deadline: Open immediately until all projects awarded

The Case Comprehensive Cancer Center is providing funding for Pilot Projects to utilize the newly designated SOM/UH Integrated Microbiome Core (IMC). The IMC offers cutting edge sequencing technology for analysis of the micro- and myco-biomes (16S, ITS, bacterial Case CCC logo genomics, metagenomics and metatranscriptomics). Full-service offerings are available including help with experimental design, nucleic acid isolation, generation of genomic data and data analysis. This RFA is open to all Case CCC Members and applications will be accepted immediately on a rolling basis until all pilot award slots (6) are filled. Proposals cannot be concurrently funded by other sources or by the Cancer Center.

Award Description
  • Up to 6 research projects will be funded. Total funds committed to this RFA are $150,000.
  • Each research project can request a budget of up to $25,000 for one year.
    • Funds should be sufficient to cover the cost to collect 96 samples, extract nucleic acid, generate and analyze genomic data.
  • Research projects should be completed within one year from the time IRB approval is obtained.
  • Funds must be expended within this 12 month funding period, as no-cost extensions will not be granted.
Astellas Oncology C 3 Prize
Deadline: July 15, 2019

The Astellas Oncology C3 prize is currently accepting applications from innovators.  This year, they identified c3 prize logo three core challenges related to unmet needs, and applicants can submit their ideas in one of these three categories:
  • Cancer Care JourneyIdeas to help improve the patient experience, ease decision-making, and navigate everyday care.
  • Cancer Health Disparities: Ideas to reduce the unequal burden of cancer care, with a focus on tools and resources that reach underserved populations in the U.S. and abroad.
  • Cancer Survivorship: Ideas to address survivorship challenges and concerns.
All applications, regardless of submission category, will be considered for all prizes: Grand Prize, Innovation Prizes, and Emerging Ideas Prize. Prizes total $200,000 of funding is available to awardees, dependent upon the award.

Innovation Prize Evaluation Criteria
  • Feasibility of innovation, including ability of entrant to operationalize/implement the innovative idea for future application within six to 12 months of receiving the grant (40%)
  • Potential impact of innovation on people affected by cancer (40%)
  • Creativity and originality of innovation (10%)
  • Vision for sharing and socializing innovation across multiple audiences, to reach more people with this impactful idea/tool (10%)
Emerging Ideas Prize Evaluation Criteria
  • Potential impact of innovation on people affected by cancer (50%)
  • Creativity and originality of innovation (20%)
  • Feasibility of innovation (20%)
  • Vision for sharing and socializing innovation across multiple audiences, to reach more people with this impactful idea/tool (10%)
Gordon and Betty Moore Foundation Request for Ideas for Clinical Measures to Improve Diagnosis
Deadline: August 2, 2019

The Gordon and Betty Moore Foundation has released a
 request for Ideas  to provide assistance in the form of grants to develop innovative quality measures that promote excellence in diagnostic performance for three categories of disease - acute vascular events, infections and cancer.

3-6 projects will be awarded $250,000-$500,000 for work to be done over 12-18 months, expected to begin January 2020.  Successful applications will describe teams and partnerships that include a multidisciplinary group of experts, including clinicians with content expertise, individuals with appropriate analytic expertise and persons with experience using relevant data sources. An individual may satisfy more than one of these areas of expertise. View details and application information>
The Case CCC's Associate Director for Cancer Disparities Research Monica Webb Hooper, PhD comments on the importance of clinical trials & how the medical community is doing as a whole to recruit diverse people for studies & clinical trials.

WKYC Cleveland - June 24, 2019
Take a look inside the lab of  Cleveland Clinic  researcher and Case CCC member Justin Lathia, PhD where his team of scientists, neurosurgeons, lab techs and students like our CanSUR program scholars are working toward a cure for brain tumors.
NIH BULLETIN - Notices and Funding Opportunities
Notice to Extend PAR-17-059 National Cancer Institute Youth Enjoy Science Research Education Program (R25)

Notice of Change to PAR-19-099 Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award (U01 Clinical Trial Optional)

Notice of Change to PAR-19-100 Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award (R21 Clinical Trial Optional)

Funding Opportunities
Limited Competition: NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed)
Deadlines: September 26, 2019; June 15, 2020; June 15, 2021
Fri, June 28
Taussig Cancer Institute Grand Rounds
Eren Berber, MD
"An Update on Minimally Invasive Treatment of Malignant Liver Tumors"
8a CA5-120
Tues, July 2
UH Radiation Oncology Grand Rounds
Prateek Mendiratta, MD
Assistant Professor of Medicine, Division of Hematology and Oncology
University Hospitals Cleveland Medical Center
"Updates in Management of Advance Melanoma"
8:10a B-181
Thurs, July 4
CWRU Closed for Independence Day
Mon, July 8
Shared Resources Directors Meeting
12p WRB 1-422D

WRB Faculty Meetings with Stan Gerson
3p WRB 3-136
Thurs, July 11
Developmental Therapeutics Journal Club
9a NE6-218

Molecular Biology and Microbiology Virology Journal Club
1p SOM W203
Fri, July 12
Center of Excellence Retreat in Lymphoid Malignancies Research
Contact Becky Habecker to RSVP at
8a-4:30p Intercontinental

Deadline: Open

Deadline: Open

Deadline: Open
Case Comprehensive Cancer Center